![](/img/cover-not-exists.png)
Phase I and pharmacokinetic study of erlotinib (OSI-774) in combination with docetaxel in squamous cell carcinoma of the head and neck (SSCHN)
Eric H. Kraut, Christopher Rhoades, Yilong Zhang, Hao Cheng, Josephine Aimiumu, Ping Chen, James Lang, Donn C. Young, Amit Agrawal, Janet Dancey, Kenneth K. Chan, Michael R. GreverVolume:
67
Language:
english
Pages:
8
DOI:
10.1007/s00280-010-1332-y
Date:
March, 2011
File:
PDF, 278 KB
english, 2011